Payer Denials and Prior Authorization Delays Are Top RCM Concerns

Why It Matters

Denial and authorization bottlenecks erode cash flow and raise administrative costs, forcing providers to adopt AI and outsourcing to protect margins.

Key Takeaways

• 88% cite payer denials as primary revenue‑cycle obstacle
• 74% experience growing prior‑authorization delays
• Only 2% have fully integrated AI across RCM operations
• 66% outsource all or part of revenue cycle to vendors
• 20% report claim denial rates exceeding 5%

Pulse Analysis

Hospitals are grappling with a perfect storm of payer denials and sluggish prior‑authorization processes, which together threaten cash‑flow stability and inflate operating expenses. The HFMA/Guidehouse survey shows that nearly nine in ten providers view claim disagreements as a barrier to timely reimbursement, while three‑quarters report worsening authorization delays. These friction points not only delay payments but also increase the workload for billing teams, amplifying the impact of existing workforce shortages and compliance pressures.

Artificial intelligence offers a tempting remedy, yet adoption remains uneven. Although 78% of respondents leverage AI for routine, manual revenue‑cycle tasks, only a fraction—2%—have fully integrated intelligent platforms across the entire RCM workflow. The gap reflects concerns over data governance, the need for human oversight, and the complexity of retrofitting legacy systems. Moreover, 59% of executives admit they have not yet deployed AI in the revenue cycle, and 42% are still exploring options, indicating a cautious but growing interest in point‑solution implementations.

In response to staffing constraints and the urgency to accelerate reimbursements, two‑thirds of providers are outsourcing portions of their revenue cycle to managed‑services vendors. This trend underscores a strategic shift toward external expertise that can combine technology with specialized knowledge of payer contracts. As AI matures, providers that blend robust payer‑strategy management with scalable automation are likely to reduce denial rates, shorten authorization timelines, and improve overall financial performance, positioning themselves competitively in an increasingly cost‑sensitive healthcare market.